CDK5 and colorectal carcinoma: We observed an increase in CDK5 kinase activity following Sn38 treatment in both HCT116 and HT29 cells (Figure 3A), indicating that CDK5 is among the early proteins activated in CRC cells after exposure to irinotecan.